Literature DB >> 16418769

A comparison of the signal pathways between the TNF alpha- and oridonin-induced murine L929 fibrosarcoma cell death.

Jian Huang1, Lijun Wu, Shin-Ichi Tashiro, Satoshi Onodera, Takashi Ikejima.   

Abstract

Oridonin, an active component isolated from Rabdosia rubescences, has been reported to have antitumor effects. In this study, we compared the signal transduction pathways between TNFalpha-and oridonin-induced L929 cell death. Oridonin and TNFalpha initiated apoptotic morphologic changes, but DNA fragmentation was found in TNFalpha-treated L929 cells but not in oridonin-treated ones. The pan-caspase inhibitor (z-VAD-fmk), caspase-8 inhibitor (z-IETD-fmk) and caspase-3 inhibitor (z-DEVD-fmk) augmented oridonin-and TNFalpha-induced cell death. However, the caspase-9 inhibitor (z-LEHD-fmk) only increased oridonin-induced L929 cell death. Moreover, poly (ADPribose) polymerase (PARP) was cleaved in oridonin-treated L929 cells but not in the TNFalpha-treated groups, and the caspase-3 inhibitor (z-DEVD-fmk) failed to inhibit PARP cleavage. These results showed that only oridonin-induced L929 cell death required PARP degradation in a caspase-3 independent manner. In addition, oridonin increased the ratio of Bax/Bcl-2 protein expression, but TNFalpha did not. TNFalpha induced p38 and ERK activation, whereas oridonin triggered only ERK activation. We also investigated the effect of oridonin on intracellular TNFalpha expression, and found that oridonin augmented endogenous pro-TNFalpha expression and its upstream protein IkB phosphorylation. These results indicated that although oridonin promoted endogenous pro-TNFalpha expression, a great difference existed between the signal pathways through which TNFalpha-and oridonin-induced cell death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16418769     DOI: 10.18926/AMO/31960

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  12 in total

Review 1.  The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases.

Authors:  Hallie M Blevins; Yiming Xu; Savannah Biby; Shijun Zhang
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

2.  Intra-Organ Delivery of Nanotherapeutics for Organ Transplantation.

Authors:  Bilal Hussain; Vivek Kasinath; Joren C Madsen; Jonathan Bromberg; Stefan G Tullius; Reza Abdi
Journal:  ACS Nano       Date:  2021-10-29       Impact factor: 18.027

3.  Oridonin induces apoptosis and autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53 positive-feedback loop signaling pathway.

Authors:  Yuan-chao Ye; Hong-ju Wang; Lei Xu; Wei-wei Liu; Bin-bin Liu; Shin-Ichi Tashiro; Satoshi Onodera; Takashi Ikejima
Journal:  Acta Pharmacol Sin       Date:  2012-07-30       Impact factor: 6.150

Review 4.  Oridonin: targeting programmed cell death pathways as an anti-tumour agent.

Authors:  Z Liu; L Ouyang; H Peng; W-Z Zhang
Journal:  Cell Prolif       Date:  2012-12       Impact factor: 6.831

Review 5.  Molecular Insight in the Multifunctional Effects of Oridonin.

Authors:  Brice Ayissi Owona; Herman J Schluesener
Journal:  Drugs R D       Date:  2015-09

6.  Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity.

Authors:  Hongbin He; Hua Jiang; Yun Chen; Jin Ye; Aoli Wang; Chao Wang; Qingsong Liu; Gaolin Liang; Xianming Deng; Wei Jiang; Rongbin Zhou
Journal:  Nat Commun       Date:  2018-06-29       Impact factor: 14.919

Review 7.  Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors.

Authors:  Yang Yang; Huanan Wang; Mohammed Kouadir; Houhui Song; Fushan Shi
Journal:  Cell Death Dis       Date:  2019-02-12       Impact factor: 8.469

Review 8.  Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection.

Authors:  Jimin Xu; Eric A Wold; Ye Ding; Qiang Shen; Jia Zhou
Journal:  Molecules       Date:  2018-02-22       Impact factor: 4.411

Review 9.  Pharmacological Inhibitors of the NLRP3 Inflammasome.

Authors:  Ayesha Zahid; Bofeng Li; Arnaud John Kombe Kombe; Tengchuan Jin; Jinhui Tao
Journal:  Front Immunol       Date:  2019-10-25       Impact factor: 7.561

10.  Oridonin Prolongs the Survival of Mouse Cardiac Allografts by Attenuating the NF-κB/NLRP3 Pathway.

Authors:  Xiaoxiao Du; Weitao Que; Xin Hu; Xiao Yu; Wen-Zhi Guo; Shuijun Zhang; Xiao-Kang Li
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.